The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2019

Filed:

Mar. 17, 2015
Applicant:

Osprey Medical, Inc., Minnetonka, MN (US);

Inventors:

Matthew M. Burns, Orono, MN (US);

Tuan M. Doan, Burnsville, MN (US);

Rodney L. Houfburg, Prior Lake, MN (US);

David M. Kaye, Beaumaris, AU;

Daniel R. Mans, Victoria, MN (US);

Todd J. Mortier, Mound, MN (US);

Assignee:

Osprey Medical, Inc., Minnetonka, MN (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/14 (2006.01); A61M 5/00 (2006.01); A61M 5/142 (2006.01); F04B 11/00 (2006.01); A61M 5/48 (2006.01); A61M 5/168 (2006.01); A61M 25/00 (2006.01); A61M 5/145 (2006.01); A61M 39/24 (2006.01); G06F 19/00 (2018.01);
U.S. Cl.
CPC ...
A61M 5/1413 (2013.01); A61M 5/007 (2013.01); A61M 5/145 (2013.01); A61M 5/14212 (2013.01); A61M 5/16881 (2013.01); A61M 5/48 (2013.01); A61M 5/482 (2013.01); A61M 5/484 (2013.01); A61M 5/488 (2013.01); A61M 25/0075 (2013.01); A61M 39/24 (2013.01); F04B 11/0033 (2013.01); G06F 19/00 (2013.01); G06F 19/3468 (2013.01); A61M 5/14216 (2013.01); A61M 2025/0076 (2013.01); A61M 2039/2413 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3334 (2013.01); A61M 2205/3337 (2013.01); A61M 2205/3341 (2013.01); A61M 2205/3344 (2013.01); A61M 2205/3355 (2013.01); A61M 2206/22 (2013.01); A61M 2210/125 (2013.01); A61M 2210/127 (2013.01); G06F 19/3456 (2013.01);
Abstract

Devices, systems and methods for controlling, regulating, altering, transforming or otherwise modulating the delivery of a substance to a delivery site. The devices, systems and methods optimize the delivery of the substance to an intended site, such as a vessel, vascular bed, organ and/or other corporeal structures, while reducing inadvertent introduction or reflux substance to other vessels, vascular beds, organs, and/or other structures, including systemic introduction.


Find Patent Forward Citations

Loading…